Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis-Reference-Cited by-同舟云学术

Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis

Published:2006-12 Issue:6 Volume:260 Page:509-516
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

NORRBY-TEGLUND A.,HAQUE K. N.,HAMMARSTRÖM L.

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2796.2006.01726.x/fullpdf

Reference65 articles.

1. The Epidemiology of Sepsis in the United States from 1979 through 2000

2. Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coli

3. PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPID

4. Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin

5. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of polyclonal and monoclonal based antibodies as promising potential therapy for treatment of sepsis: A systematic review;New Microbes and New Infections;2024-08

2. Multifaceted Tissue-Protective Functions of Polyvalent Immunoglobulin Preparations in Severe Infections—Interactions with Neutrophils, Complement, and Coagulation Pathways;Biomedicines;2023-11-10

3. INFECCIÓN POR SARS-CoV-2/ COVID-19 Y SÍNDROME TORÁCICO AGUDO EN NIÑOS CON DREPANOCITOSIS: REPORTE DE CASO;Revista de la Facultad de Ciencias;2023-07-01

4. Polyvalent human immunoglobulin for infectious diseases: Potential to circumvent antimicrobial resistance;Frontiers in Immunology;2023-01-09

5. Adjuvant therapies and sepsis from multidrug resistant bacteria: a narrative review;Signa Vitae;2023